E-LIB Suche - Ergebnisse für: Savarino, E.

1

P215 Mir-135b, an Early Biomarker of Sporadic and IBD-Relat..:

Barberio, B ; Borga, C ; Giada, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i540-i541 , 2024

2

DOP79 Promising efficacy of biologicals and small molecules..:

Verstockt ., B ; Taelman, T ; Vavricka, S R...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i219-i221 , 2024

Link: https://doi.org/10.1093/..

3

P220 IBD-Disk: italian translation and validation in a popu..:

Nardone, O M ; Calabrese, G ; Allocca, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i551-i553 , 2024

Link: https://doi.org/10.1093/..

4

P544 Ustekinumab safety and effectiveness in ulcerative col..:

Mocci, G ; Scaldaferri, F ; Pugliese, D...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1072-i1073 , 2024

Link: https://doi.org/10.1093/..

5

P908 Real-life effectiveness and safety of tofacitinib and ..:

Noviello, D ; Savarino, E ; Fries, W...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1660-i1661 , 2024

Link: https://doi.org/10.1093/..

6

P735 JAK inhibitors and S1P receptor modulators for the tre..:

Testa, G ; Ribaldone, D G ; Verstockt, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1377-i1379 , 2024

Link: https://doi.org/10.1093/..

7

P413 Bowel Urgency in patients with Ulcerative Colitis: pre..:

Nardone, O M ; Calabrese, G ; Allocca, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i853-i853 , 2024

Link: https://doi.org/10.1093/..

8

T.05.2 DO WE NEED THREE DIFFERENT TYPES OF ESOPHAGOGASTRIC ..:

Venturini, A. ; Stefani Donati, A. ; Visaggi, P....
Digestive and Liver Disease. 55 (2023) - p. S154-S155 , 2023

Link: https://doi.org/10.1016/..

9

OC.16.4 ASSOCIATION BETWEEN SYSTEMIC SCLEROSIS SEVERITY AND..:

Ribolsi, M. ; Savarino, E. ; Marabotto, E....
Digestive and Liver Disease. 55 (2023) - p. S132 , 2023

Link: https://doi.org/10.1016/..

10

OC.03.3 MOLECULAR AND MICROBIOTA PROFILING IN EOSINOPHILIC ..:

Barchi, A. ; Massimino, L. ; Mandarino, F.V....
Digestive and Liver Disease. 55 (2023) - p. S91 , 2023

Link: https://doi.org/10.1016/..

11

T.01.9 WHICH CHRONOPTYPE IS MORE FREQUENT IN PATIENTS WITH ..:

Stefani Donati, D. ; Venturini, A. ; Visaggi, P....
Digestive and Liver Disease. 55 (2023) - p. S138 , 2023

Link: https://doi.org/10.1016/..

12

P505 Real word long-term efficacy and safety of vedolizumab..:

Mocci, G ; Maconi, G ; Onidi, F M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i635-i636 , 2023

Link: https://doi.org/10.1093/..

13

P778 Effectiveness and safety of a second-line rescue thera..:

García, M J ; Riestra, S ; Amiot, A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i911-i912 , 2023

Link: https://doi.org/10.1093/..

14

P674 Ustekinumab is the preferred biological agent in IBD p..:

Verstockt ., B ; Vieujean, S ; Truyens, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i805-i806 , 2023

Link: https://doi.org/10.1093/..

15

T.05.1 IMPEDANCE-PH FINDINGS CONFIRM THAT GRADE B ESOPHAGIT..:

Visaggi, P. ; Baiano Svizzero, F. ; Stefani Donati, D....
Digestive and Liver Disease. 55 (2023) - p. S154 , 2023

Link: https://doi.org/10.1016/..